Survivorship After Primary Total Hip Arthroplasty in Solid-Organ Transplant Patients

Brian P. Chalmers, Cameron K. Ledford, Joseph M. Statz, Kevin I. Perry, Tad M. Mabry, Arlen D. Hanssen, Matthew P. Abdel

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Background Although a growing number of primary total hip arthroplasties (THAs) are being performed on solid-organ transplant (SOT) recipients, long-term patient and implant survivorships have not been well studied in contemporary transplant and arthroplasty practices. Methods A total of 136 THAs (105 patients) with prior SOT were retrospectively reviewed from 2000 to 2013 at mean clinical follow-up of 5 years. The mean age was 59 years, with 39% being females. The most common SOT was renal (56%), followed by liver (24%). Results Patient mortality was 3.8% and 13.3% at 2 and 5 years, respectively. There were 9 revisions (6.6%), including 5 (4%) for deep periprosthetic infection. Implant survivorship free of any revision was 95% and 94% at 2 and 5 years, respectively. Transplant type or surgical indication did not significantly impact patient or implant survivorship. Conclusion Compared with the general population, SOT patients undergoing THA have slightly higher mortality rates at 5 years. Implant survivorship free of revision was slightly lower than the general population, primarily due to an increased risk of periprosthetic joint infection.

Original languageEnglish (US)
Pages (from-to)2525-2529
Number of pages5
JournalJournal of Arthroplasty
Issue number11
StatePublished - Nov 1 2016


  • deep periprosthetic joint infection
  • solid-organ transplant
  • survivorship
  • total hip arthroplasty

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine


Dive into the research topics of 'Survivorship After Primary Total Hip Arthroplasty in Solid-Organ Transplant Patients'. Together they form a unique fingerprint.

Cite this